These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5555696)

  • 1. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbodies in experimentally altered cells. VII. CPID-induced hepatic microbody proliferation in the absence of significant catalase synthesis.
    Reddy J; Chiga M; Bunyaratvej S; Svoboda D
    J Cell Biol; 1970 Jan; 44(1):226-34. PubMed ID: 5409461
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation of liver catalase synthesis in rats by ethyl-alpha-p-chlorophenoxyisobutyrate.
    Reddy J; Chiga M; Svoboda D
    Biochem Biophys Res Commun; 1971 Apr; 43(2):318-24. PubMed ID: 4996023
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphological and biochemical changes in rat liver during the early stages of ethyl chlorophenoxyisobutyrate administration.
    Kaneko A; Sakamoto S; Morita M; Onoe T
    Tohoku J Exp Med; 1969 Sep; 99(1):81-101. PubMed ID: 4390771
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.
    Svoboda D; Azarnoff D; Reddy J
    J Cell Biol; 1969 Mar; 40(3):734-46. PubMed ID: 5765763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 7. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease in aldolase activity in the livers of clofenapate-treated rats.
    Ramasarma T; Ting SM; Horecker BL
    Indian J Biochem; 1971 Jun; 8(2):87-9. PubMed ID: 4259437
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of clofibrate on Tetrahymena.
    Blum JJ; Wexler JP
    Mol Pharmacol; 1968 Mar; 4(2):155-61. PubMed ID: 5645611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
    Araki Y; Amagase H
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
    Brown DF
    Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
    [No Abstract]   [Full Text] [Related]  

  • 13. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethyl- -p-chlorophenoxyisobutyrate induced hepatic microbody proliferation in rat liver and ubiquinone concentration.
    Reddy J; Svoboda D
    Experientia; 1971 Sep; 27(9):1059-61. PubMed ID: 5116132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of ethyl chlorophenoxyisobutyrate on postprandial lipemia].
    Beaumont JL; Menard J; Beaumont V
    Rev Atheroscler (Paris); 1966; 8(1):21-6. PubMed ID: 5960551
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.
    Platt DS; Thorp JM
    Biochem Pharmacol; 1966 Jul; 15(7):915-25. PubMed ID: 4961207
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.
    Kurup CK; Aithal HN; Ramasarma T
    Biochem J; 1970 Mar; 116(5):773-9. PubMed ID: 5441366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
    Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
    Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of liver and kidney catalase to alpha-p-chlorophenoxyisobutyrate (clofibrate) in C57B1/6J male mice of different ages.
    Baird MB; Zimmerman JA; Massie HR; Samis HV
    Gerontologia; 1974; 20(3):169-78. PubMed ID: 4461328
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate.
    Spritz N; Lieber CS
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):147-9. PubMed ID: 5902917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.